Aluminum-induced osteomalacia: an explanation.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 6742013)

Published in Am J Nephrol on January 01, 1984

Authors

W C Thomas, J L Meyer

Articles citing this

Water content of aluminum, dialysis dementia, and osteomalacia. Environ Health Perspect (1985) 0.86

Articles by these authors

Ecology. Synthesizing U.S. river restoration efforts. Science (2005) 7.26

Control of nitrogen export from watersheds by headwater streams. Science (2001) 4.20

The effect of hypoparathyroidism on the aging skeleton. J Am Geriatr Soc (1990) 2.01

Administrative centralization versus decentralization and the role of generalists and specialists. Am J Public Health Nations Health (1968) 1.91

Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys (1984) 1.88

Control of crystallization in urine. Am J Med (1968) 1.66

Fish schools: an asset to corals. Science (1983) 1.65

The recognition and isolation from urine and serum of a peptide inhibitor to calcification. Johns Hopkins Med J (1967) 1.54

The effects of hyperthermia on normal mesenchymal tissues. Application of a histologic grading system. Arch Pathol Lab Med (1983) 1.25

Carbon and nitrogen transfer from a desert stream to riparian predators. Oecologia (2002) 1.24

Gastroscopic removal of an adjustable gastric band after partial intragastric migration. Obes Surg (2003) 1.23

A thermodynamic analysis of the secondary transition in the spontaneous precipitation of calcium phosphate. Calcif Tissue Res (1978) 1.18

Effect of iodinated water supplies on thyroid function. J Clin Endocrinol Metab (1966) 1.12

Permanently decreased renal blood flow and hypertension after lithotripsy. N Engl J Med (1989) 1.07

A urinary peptide with extraordinary inhibitory powers against biological "calcification" (deposition of hydroxyapatite crystals). Trans Assoc Am Physicians (1966) 1.07

Urinary tract stone after small bowel bypass for morbid obesity. Am J Surg (1974) 1.06

Pyrophosphate and the mineralizing potential of urine. Clin Sci (1966) 1.05

A thermodynamic analysis of the amorphous to crystalline calcium phosphate transformation. Calcif Tissue Res (1978) 1.02

Extracorporeal shock-wave lithotripsy: long-term complications. AJR Am J Roentgenol (1988) 1.01

The maturation of crystalline calcium phosphates in aqueous suspensions at physiologic pH. Calcif Tissue Res (1977) 1.00

Mineralization of human and bovine tissue in vitro. Am J Pathol (1967) 0.98

Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol (1975) 0.96

Epitaxial relationships in urolithiasis: the brushite-whewellite system. Clin Sci Mol Med (1977) 0.96

The role of trace metals in calcium urolithiasis. Invest Urol (1977) 0.95

Mesenteric Vascular Occlusion. Ann Surg (1931) 0.94

The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite. Calcif Tissue Res (1973) 0.94

Inhibition of mineralization by hydrolysates of phytic acid. Johns Hopkins Med J (1972) 0.92

Diplopia and loss of accommodation due to chloroquine. Arthritis Rheum (1970) 0.91

Epitaxial relationships in urolithiasis: the calcium oxalate monohydrate-hydroxyapatite system. Clin Sci Mol Med (1975) 0.90

One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial. Hum Reprod (2004) 0.89

Urinary supersaturation with calcium oxalate before and during orthophosphate therapy. J Urol (1976) 0.88

Production and turnover of planktonic bacteria in two southeastern blackwater rivers. Appl Environ Microbiol (1986) 0.87

Kidney stones, urine, and cement. Md Med J (1988) 0.87

Relationship between experimentally induced crystalluria and relative supersaturation of various stone salts in rats. Urol Res (1984) 0.86

The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol (1976) 0.85

Abnormal diurnal variation of plasma cortisol in patients with renovascular hypertension. J Clin Endocrinol Metab (1967) 0.84

Parathyroid adenomas in chronic rickets. Am J Med (1970) 0.84

The effect of pH and temperature on the crystal growth of hydroxyapatite. Arch Oral Biol (1972) 0.84

Growth of calcium oxalate crystals. I. A model for urinary stone growth. Invest Urol (1975) 0.83

Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi. Trans Am Clin Climatol Assoc (1972) 0.82

Inorganic phosphates in the treatment of renal calculi. Mod Treat (1967) 0.82

Automated phosphorus method employing ferrous sulfate as the reducing agent. Am J Med Technol (1970) 0.82

Some Observations on Rachitic Rat Cartilage of Probable Significance in the Etiology of Renal Calculi. Trans Am Clin Climatol Assoc (1959) 0.81

Copper(II)--histidine complexes. J Am Chem Soc (1970) 0.81

Low-renin hypertension after extracorporeal shock wave lithotripsy. JAMA (1989) 0.81

Extracorporeal shock-wave lithotripsy. Ann Intern Med (1984) 0.81

Fibrinogenesis imperfecta ossium. Trans Am Clin Climatol Assoc (1969) 0.81

The cardiotoxicity of hydrogen cyanide as a component of polymer pyrolysis smokes. Toxicol Appl Pharmacol (1982) 0.80

The influence of fluoride on apatite formation from unstable supersaturated solutions at pH 7.4. J Dent Res (1978) 0.80

Apert's syndrome: (acrocephalosyndactylism). J Foot Surg (1981) 0.80

Influence of phosphocitrate, a potent inhibitor of hydroxyapatite crystal growth, on mineralization of cartilage and bone. Biochem Biophys Res Commun (1980) 0.80

Heat-induced protection of mice against thermal death. Cancer Res (1983) 0.80

Early albumin infusion to infants at risk for respiratory distress. Arch Dis Child (1973) 0.80

Anatomical site-specific modalities for hyperthermia. Cancer Res (1984) 0.79

Breast cancer: chest wall hyperthermia-electron beam therapy. Front Radiat Ther Oncol (1991) 0.79

Symposium on renal lithiasis. Medical aspects of renal calculous disease. Treatment and prophylaxis. Urol Clin North Am (1974) 0.79

Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system. Invest Urol (1981) 0.79

[Prenatal diagnosis of chromosomal anomalies by chorionic villi sampling: culture technic and preliminary results]. C R Seances Soc Biol Fil (1986) 0.79

A system of exposing animals to smoke generated in a steady-state fashion. Environ Res (1980) 0.79

Thermal sensitivity and thermotolerance in normal porcine tissues. Cancer Res (1983) 0.79

Calcification inhibitors in rat and human serum and plasma. Biochim Biophys Acta (1984) 0.78

Preclinical feasibility study of NMP179, a nuclear matrix protein marker for cervical dysplasia. Acta Cytol (1999) 0.78

Iodine disinfection of water. Arch Environ Health (1969) 0.78

Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. I. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium phosphate crystal growth. J Urol (1982) 0.78

Trace metal-citric acid complexes as inhibitors of calcification and crystal growth. II. Effects of Fe(III), Cr(III) and Al(III) complexes on calcium oxalate crystal growth. J Urol (1982) 0.78

Effects of an iodinated water supply. Trans Am Clin Climatol Assoc (1979) 0.78

Extracorporeal shock-wave lithotripsy: prevalence of renal stones 3-21 months after treatment. AJR Am J Roentgenol (1988) 0.78

Determination of calcium phosphate inhibitor activity. Critical assessment of the methodology. Miner Electrolyte Metab (1984) 0.78

Cushing's disease with cyclic hormonogenesis and diabetes insipidus. Neurosurgery (1979) 0.78

Effect of stannous and fluoride ions on the rate of crystal growth of hydroxyapatite. J Dent Res (1972) 0.77

The clinical efficacy of localized hyperthermia. Cancer Res (1984) 0.77

Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. Int J Radiat Oncol Biol Phys (1990) 0.77

Experience with a multitransducer ultrasound system for localized hyperthermia of deep tissues. IEEE Trans Biomed Eng (1984) 0.77

Changes in pyrophosphatase activity during the de novo mineralization associated with cartilage and bone formation. Arch Biochem Biophys (1985) 0.77

Comparison of the maximum tolerated dose (MTD) dermal response in three strains of mice following repeated exposure to acrylic acid. Food Chem Toxicol (1995) 0.77

Hyperthermia as an anticancer modality--a historical perspective. Front Radiat Ther Oncol (1984) 0.76

The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates. Calcif Tissue Res (1977) 0.76

Normal-tissue effects of irradiation for Kaposi's sarcoma/AIDS. Front Radiat Ther Oncol (1989) 0.76

Choledochocele demonstrated by computed tomographic cholangiography: report of a case. Surg Today (2000) 0.76

Influence of aluminum on mineralization during matrix-induced bone development. Kidney Int (1986) 0.76

Inhibition of calcium phosphate crystallization by nucleoside phosphates. Calcif Tissue Res (1974) 0.76

Formation constants for interaction of citrate with calcium and magnesium ions. Anal Biochem (1974) 0.75

Expression of integrated hepatitis B virus DNA in PLC/PRF/5, Hep 3B, and L6EC3 cell lines detected by in situ hybridisation. Med Biol (1986) 0.75

Effect of alkali administration on calcium metabolism. J Clin Endocrinol Metab (1967) 0.75

Genesis of osteomalacia following gastroenterostomy. Trans Am Clin Climatol Assoc (1967) 0.75

The effects of induced hypercalcemia on the activity of the parathyroid glands. Am J Pathol (1966) 0.75

Production of calcification inhibitors by rat calvaria and bone cells in culture. Clin Orthop Relat Res (1988) 0.75

[A case from practice (100). Patient: Mr. A.D., born 4-1-1961, construction worker]. Schweiz Rundsch Med Prax (1987) 0.75

Clinical and technical considerations in planning a course of hyperthermia and irradiation. Front Radiat Ther Oncol (1987) 0.75

Radiotherapy treatment planning for the non-Hodgkin's lymphomas. Front Radiat Ther Oncol (1987) 0.75

Corticosteroids. Int Anesthesiol Clin (1968) 0.75

[The case from practice (79). Patient: Mr. S.T., born 10-4-1951, doorman]. Schweiz Rundsch Med Prax (1987) 0.75

A proposal for revision of curriculums of schools of public health. Public Health Rep (1969) 0.75

Stanford University institutional report. Phase I evaluation of equipment for hyperthermia treatment of cancer. Int J Hyperthermia (1988) 0.75

[A simple rapid method of culturing chorionic villi. Identification and description of maternal cells in culture]. Ann Genet (1987) 0.75

Thyroid disease. Int Anesthesiol Clin (1968) 0.75

Urinary tract calculi. Ann Intern Med (1968) 0.75